Positive and Negative Regulation of IL-17 in Experimental Arthritis
IL-17 在实验性关节炎中的正向和负向调节
基本信息
- 批准号:7470800
- 负责人:
- 金额:$ 1.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-06-01 至 2008-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAntigensArthritisAutoantigensAutoimmune ProcessBindingCD4 Positive T LymphocytesCell ProliferationCellsChronicClassificationClonal ExpansionCollagen ArthritisCollagen Type IIDBA/1 MouseDefectDevelopmentEpigenetic ProcessExperimental ArthritisGene Expression RegulationGenesGoalsHelper-Inducer T-LymphocyteImmunizationInflammationInflammatoryInterferonsInterleukin-17Interleukin-2Interleukin-4Interleukin-6InterleukinsKnock-outLeadMediatingModelingMolecularMouse StrainsMusNuclear Hormone ReceptorsOrphanPathogenesisPredispositionProductionProtein OverexpressionRegulationResistanceRheumatoid ArthritisSecondary toSignal TransductionStimulusT-Cell ReceptorT-LymphocyteTestingTransforming Growth FactorsTransgenic MiceTransgenic Organismscytokinedesignin vivointerleukin-23microbialnovel therapeuticspromoterresponsetranscription factor
项目摘要
DESCRIPTION (provided by applicant): Interleukin (IL)-17 has emerged to be a critical inflammatory cytokine in the pathogenesis of rheumatoid arthritis (RA) and arthritis models. CD4+T cells producing IL-17 has recently been identified as a distinct subset of Th cells and designated Th17. The differentiation of Th17 subset from naive CD4+ T cells requires stimulation in the presence of IL-6 and transforming growth factor (TGF)-p. IL-23 is required for Th17 clonal expansion. Interferon (IFN)-y, IL-4, IL-27, IL-25 and IL-2 negatively regulate Th17 development. Our preliminary studies in murine collagen-induced arthritis (CIA) model showed that in response to collagen type II (Cll) immunization, CIA resistant C57BL/6 (B6) mice expressed high IFN-y and low IL-17 while CIA susceptible DBA/1 mice expressed low IFN-y and high IL-17. Moreover, IFN-y suppressed Cll stimulated IL-17 production. IFN-y knockout B6 mice displayed significantly enhanced IL-17 response and developed CIA that was mediated by IL-17. RORyt is an orphan nuclear hormone receptor that has been implicated as master transcription factor for IL-17. We showed that overexpression of RORyt markedly increased IL-17 production by CD4+ T cells. The goals of this proposal are to define the mechanisms of IFN-y mediated suppression of IL-17 and factors positively regulate IL-17 production during arthritis. We plan to investigate the mechanisms for low IFN-y response in DBA/1 mice and cellular and molecular mechanisms of IFN-y mediated suppression of IL-17 by focusing on effects of IFN^y on RORyt expression and binding to IL-17 gene promoter. Finally, using RORyt transgenic mice and Cll TCR transgenic mice we will examine what cytokines are required for development of arthritogenic Th17 cells and arthritis expression and chronicity. Understanding the details of how arthritogenic Th17 cells are regulated during arthritis models will provide useful information for novel therapeutic design in RA by targeting factors regulating IL-17 expression.
描述(由申请人提供):白介素17已成为类风湿性关节炎(RA)和关节炎模型发病机制中的关键炎症细胞因子。产生IL-17的CD4+T细胞最近被确认为Th细胞的一个独特的亚群,并命名为Th17。从初始的CD4+T细胞分化为Th17亚群需要在IL-6和转化生长因子-β的刺激下进行。Th17的克隆性扩增需要IL-23。干扰素-γ、IL-4、IL-27、IL-25和IL-2负向调节Th17的发育。我们在胶原性关节炎(CIA)小鼠模型上的初步研究表明,对于II型胶原(CLL)免疫,CIA耐药的C57BL/6(B6)小鼠表达高的干扰素-γ和低的IL-17,而对CIA敏感的DBA/1小鼠则表达低的干扰素-γ和高的IL-17。此外,干扰素-γ还能抑制CLL刺激的IL-17的产生。干扰素-γ基因敲除的B6小鼠表现出显著增强的IL-17反应,并产生由IL-17介导的CIA。RORyt是一种孤儿核激素受体,被认为是IL-17的主要转录因子。我们发现过表达RORyt显著增加了CD4+T细胞产生IL-17。这项建议的目的是明确干扰素-γ介导的抑制IL-17的机制,以及在关节炎过程中正向调节IL-17产生的因素。我们计划通过研究干扰素对小鼠RORyt表达和与IL-17基因启动子结合的影响,来探讨DBA/1小鼠低干扰素反应的机制,以及干扰素-γ抑制IL-17的细胞和分子机制。最后,使用RORyt转基因小鼠和CLL TCR转基因小鼠,我们将检查哪些细胞因子是导致关节炎的Th17细胞发展和关节炎表达和慢性化所必需的。了解致关节炎Th17细胞在关节炎模型中的调控细节,将通过靶向调节IL-17表达的因子为RA的新治疗设计提供有用的信息。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CONG-QIU CHU其他文献
CONG-QIU CHU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CONG-QIU CHU', 18)}}的其他基金
Stimulation of Native Joint-resident Precursors for Cartilage Repair in Osteoarthritis
刺激天然关节前体促进骨关节炎软骨修复
- 批准号:
10514590 - 财政年份:2020
- 资助金额:
$ 1.15万 - 项目类别:
Stimulation of Native Joint-resident Precursors for Cartilage Repair in Osteoarthritis
刺激天然关节前体促进骨关节炎软骨修复
- 批准号:
10293586 - 财政年份:2020
- 资助金额:
$ 1.15万 - 项目类别:
Stimulation of Native Joint-resident Precursors for Cartilage Repair in Osteoarthritis
刺激天然关节前体促进骨关节炎软骨修复
- 批准号:
10015959 - 财政年份:2020
- 资助金额:
$ 1.15万 - 项目类别:
Regeneration of hyaline cartilage in situ with bone marrow mesenchymal stem cells
骨髓间充质干细胞原位再生透明软骨
- 批准号:
10058203 - 财政年份:2016
- 资助金额:
$ 1.15万 - 项目类别:
Regeneration of hyaline cartilage in situ with bone marrow mesenchymal stem cells
骨髓间充质干细胞原位再生透明软骨
- 批准号:
9206892 - 财政年份:2016
- 资助金额:
$ 1.15万 - 项目类别:
Positive and Negative Regulation of IL-17 in Experimental Arthritis
IL-17 在实验性关节炎中的正向和负向调节
- 批准号:
8074987 - 财政年份:2008
- 资助金额:
$ 1.15万 - 项目类别:
Positive and Negative Regulation of IL-17 in Experimental Arthritis
IL-17 在实验性关节炎中的正向和负向调节
- 批准号:
7665275 - 财政年份:2008
- 资助金额:
$ 1.15万 - 项目类别:
Positive and Negative Regulation of IL-17 in Experimental Arthritis
IL-17 在实验性关节炎中的正向和负向调节
- 批准号:
7849576 - 财政年份:2008
- 资助金额:
$ 1.15万 - 项目类别:
Positive and Negative Regulation of IL-17 in Experimental Arthritis
IL-17 在实验性关节炎中的正向和负向调节
- 批准号:
7626759 - 财政年份:2008
- 资助金额:
$ 1.15万 - 项目类别:
相似国自然基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
- 批准号:2022J011295
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
- 批准号:30801055
- 批准年份:2008
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of peptide immunotherapy for Rheumatoid Arthritis: Identification and validation of T cell epitopes from citrullinated auto-antigens.
类风湿关节炎肽免疫疗法的开发:来自瓜氨酸自身抗原的 T 细胞表位的鉴定和验证。
- 批准号:
324765 - 财政年份:2015
- 资助金额:
$ 1.15万 - 项目类别:
Operating Grants
Identifying antigens against antibodies produced in lesional synovium of rheumatoid arthritis and application of the enzyme-labeled antigen method
类风湿性关节炎病灶滑膜产生的抗体抗原的鉴定及酶标抗原法的应用
- 批准号:
21890277 - 财政年份:2009
- 资助金额:
$ 1.15万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Identification of novel citrullinated antigens in rheumatoid arthritis (RA) and the role of anti-CCP antibody in the pathogenesis of RA
类风湿性关节炎 (RA) 中新型瓜氨酸抗原的鉴定以及抗 CCP 抗体在 RA 发病机制中的作用
- 批准号:
17591033 - 财政年份:2005
- 资助金额:
$ 1.15万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Pathologic Studies on Induction of Craniomandibular Joint Arthritis is using in Rabbits Escherichia Coli Antigens
大肠杆菌抗原诱导兔颅颌关节关节炎的病理学研究
- 批准号:
13672132 - 财政年份:2001
- 资助金额:
$ 1.15万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
TRIGGERING ANTIGENS IN JUVENILE RHEUMATOID ARTHRITIS
幼年类风湿关节炎中的触发抗原
- 批准号:
2517516 - 财政年份:1995
- 资助金额:
$ 1.15万 - 项目类别:
TRIGGERING ANTIGENS IN JUVENILE RHEUMATOID ARTHRITIS
幼年类风湿关节炎中的触发抗原
- 批准号:
2083721 - 财政年份:1995
- 资助金额:
$ 1.15万 - 项目类别:
TRIGGERING ANTIGENS IN JUVENILE RHEUMATOID ARTHRITIS
幼年类风湿关节炎中的触发抗原
- 批准号:
2083720 - 财政年份:1995
- 资助金额:
$ 1.15万 - 项目类别:
TRIGGERING ANTIGENS IN JUVENILE RHEUMATOID ARTHRITIS
幼年类风湿关节炎中的触发抗原
- 批准号:
2769638 - 财政年份:1995
- 资助金额:
$ 1.15万 - 项目类别:
BORRELIA ANTIGENS AND IMMUNITY IN LYME ARTHRITIS
莱姆关节炎中的疏螺旋体抗原和免疫
- 批准号:
3021716 - 财政年份:1992
- 资助金额:
$ 1.15万 - 项目类别:
The role of cross reacting bacterial antigens in rheuma toid arthritis.
细菌抗原交叉反应在类风湿性关节炎中的作用。
- 批准号:
nhmrc : 910035 - 财政年份:1991
- 资助金额:
$ 1.15万 - 项目类别:
NHMRC Project Grants